Mitochondrial NADH dehydrogenase subunit 5
MT-ND5geneMitochondrial DNA methylation in platelets serves as a marker of platelet metabolic status and activation during thrombotic events.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationalePlatelet mtDNA methylation reflects mitochondrial bioenergetics and activation state during thrombosis.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates3
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000198786
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Platelet mitochondrial DNA methylation: A novel biomarker for myocardial infarction - A preliminary study.International journal of cardiology · 2023 · PMID 37996014 · doi